Advanced Breast Cancer (PDX) Tumor Microarrays (TMAs)

Breast Cancer Tumor Microarrays (TMAs) are essential tools in cancer research, allowing for the simultaneous high-throughput analysis of numerous breast cancer samples. These TMAs, such as Breast Cancer TMA040 and TMA050, provide researchers with a broad array of tumor samples that are vital for validating biomarkers, identifying drug targets, and conducting translational research. Utilizing these arrays, researchers can achieve deeper insights into the histopathological and molecular features of breast cancer, significantly advancing our understanding and treatment of this complex disease.